This article is part of a series on today’s philosophies regarding weight change and how digital interventions can help. In this article, we’ll look at the contribution of tracking. The article looks at standards,…
Continue Reading
What You Should Know:
– Ro, the leading direct-to-patient healthcare company, unveils ro.OS, a technology platform designed to transform the healthcare experience.
– This comprehensive system, in development for over six years, vertically integrates telehealth, lab…
Continue Reading
Jamf Pro Allows Easy Device Sharing
Jamf Pro’s setup and reset feature allows users to select the role they require, and the system will load the corresponding interface. These roles include nurse, pharmacist, technician and…
Applications are open for the 2024 Digital Health Networks Awards, the only awards that focus on recognising and celebrating the best local NHS digital health leaders across the UK. Open to members of Digital Health…
Continue Reading
What You Should Know:
– Deloitte announced today the acquisition of substantially all assets belonging to Gryphon Scientific, LLC (Gryphon). Gryphon is a leader in biosafety, biosecurity, and all-hazards preparedness and response.
– The combined expertise…
Continue Reading
As quickly as they have hit the healthcare industry, generative artificial intelligence and large language models are reshaping the healthcare landscape. And CIOs and other health IT leaders at hospitals and health systems must…
Continue Reading
What You Should Know:
– FDB (First Databank), a leading provider of drug knowledge solutions for healthcare professionals, announced today that its FDB Targeted Medication Warnings™ has received the new Toolbox designation from Epic Systems…
Continue Reading
What You Should Know:
– WebMD Ignite, a full-service growth partner for organizations across the healthcare industry, today announced HealthHub Interactive for health plans, a suite of new technology-driven solutions specifically designed to power health…
Continue Reading
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound…
Continue Reading
Accurate prediction of recurrence and progression in non-muscle invasive bladder cancer (NMIBC) is essential to inform management and eligibility for clinical trials. Despite substantial interest in developing artificial intelligence (AI) applications in NMIBC, their…
Continue Reading
